Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS)

BACKGROUND: Subcutaneous administration of Eprex(®) (epoetin alfa) in patients with chronic kidney disease (CKD) was contraindicated in the European Union between 2002 and 2006 after increased reports of anti-erythropoietin antibody-mediated pure red cell aplasia (PRCA). The Prospective Immunogenici...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrol Dial Transplant
Hauptverfasser: Macdougall, Iain C., Casadevall, Nicole, Locatelli, Francesco, Combe, Christian, London, Gerard M., Di Paolo, Salvatore, Kribben, Andreas, Fliser, Danilo, Messner, Hans, McNeil, John, Stevens, Paul, Santoro, Antonio, De Francisco, Angel L.M., Percheson, Paul, Potamianou, Anna, Foucher, Arnaud, Fife, Daniel, Mérit, Véronique, Vercammen, Els
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2015
Schlagworte:
CLINICAL SCIENCE
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4339685/
https://ncbi.nlm.nih.gov/pubmed/25239637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfu297
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge